Biotech Shares Rip Following FDA Designation Announcement
2024年10月16日 - 2:00AM
AllPennyStocks.com
A Massachusetts-based biotech company is
stealing the show so far during Tuesday’s session after it
announced that its investigational drug IMM-1-104 has received
orphan...
To read the full story on AllPennyStocks.com, click
here.
Immuneering (NASDAQ:IMRX)
過去 株価チャート
から 3 2025 まで 4 2025
Immuneering (NASDAQ:IMRX)
過去 株価チャート
から 4 2024 まで 4 2025
